SC
OCDX

Sarissa Consulting’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Sarissa Consulting’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27,455
Closed -$512K – 63
2022
Q1 		$512K Buy
+27,455
New +$494K 0.81% 29

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sarissa Consulting's OCDX Position: Q2 2022 in Review

Sarissa Consulting sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 27,455 shares — an estimated $512K sold.

Sarissa Consulting first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $512K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Sarissa Consulting reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Sarissa Consulting sold 27,455 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $512K.
  • Sarissa Consulting first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Sarissa Consulting's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $512K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Sarissa Consulting's 13F filing for Q2 2022, filed 15 Aug 2022.